All:
Dollerup OL, Chubanava S, Agerholm M, Søndergård SD, Altıntaş A, Møller AB, Høyer KF, Ringgaard S, Stødkilde-Jørgensen H, Lavery GG, Barrès R, Larsen S, Prats C, Jessen N, Treebak JT.
Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin resistant men.
J Physiol. 2019 Nov 11. doi: 10.1113/JP278752. [Epub ahead of print] PubMed PMID: 31710095.
Key pointsAbstract
- •This is the first long‐term human clinical trial to report on effects of NR on skeletal muscle mitochondrial function, content and morphology
- •NR supplementation decreases NAMPT protein abundance in skeletal muscle
- •NR supplementation do not affect NAD metabolite concentrations in skeletal muscle
- •Respiration, distribution, and quantity of muscle mitochondria are unaffected by NR
- •NAMPT in skeletal muscle correlates positively with OXPHOS Complex I, SIRT3, and SDH
Preclinical evidence suggest that ... (NR) boosts NAD+ levels and improves diseases associated with mitochondrial dysfunction. ... In a randomized, placebo‐controlled clinical trial, 40 [middle‐aged, obese, insulin‐resistant men] received 1,000 mg NR or placebo twice daily for 12 weeks. ...
Protein levels of nicotinamide phosphoribosyltransferase (NAMPT), an essential NAD+ biosynthetic enzyme in skeletal muscle, decreased 14% with NR. However, steady‐state NAD+ levels as well as gene expression and protein abundance of other NAD+ biosynthetic enzymes remained unchanged.
Neither respiratory capacity of skeletal muscle mitochondria nor abundance of mitochondrial associated proteins were affected by NR. Moreover, no changes in mitochondrial fractional area or network morphology were observed [in a subset of the participants (placebo n = 8; NR n = 8)] ...
Our data do not support the hypothesis that dietary NR supplementation has significant impact on skeletal muscle mitochondria in obese and insulin‐resistant men. Future studies on the effects of NR on human skeletal muscle may include both genders and potentially provide comparisons between young and older people.
This is a much longer-term trial than Brenner's report on NR and the NAD+ metabolome in aged, modestly overweight men (PMID 31278280, discussed here). The lack of an effect of NR on muscle NAD+ is consistent between the two reports; OTOH, the lack of even an effect on the NAD+ metabolome in this longer-term study sounds on its face to be contradictory, and would be much more surprising (I haven't yet seen the full text).
The suppression of NAMPT is something we've speculated about for a long time, as part of homeostatic adaptation to NAD+ precursor supplementation, and is here confirmed in human muscle. Despite this, there was no effect on NAD+ in muscle — presumably because NAMPT downregulation was tuned to maintain NAD+ in steady-state. It would be interesting to see if there were a time-course, though this is much different from the elevation with some modest decline seen in blood fractions.
It's surprising that while NR suppressed NAMPT in skeletal muscle (as anticipated), and that NAMPT level "correlates positively with OXPHOS Complex I, SIRT3, and SDH" (which seems to indicate that NR also suppressed these mitochondrial genes, and would also make sense), — yet despite this, there was no net effect on skeletal muscle respiratory capacity. Again, I'd like to see details and discussion from the full text.
This is obviously quite different from what's been reported in mouse liver, and seems quite different from the mouse data on exercise. The effect if any on actual muscle NAD+ has always seemed pretty modest, even in mice. And the lack of effect on metabolism — particularly glycemia — from NR that has been consistently reported in all NR studies (and most notably the lack of such effects in the previous report from this trial) is highly contradictory.
This may indeed be a straight-up species different. Certainly the lack of an effect on blood flow, fat or carbohydrate utilisation, or grip strength in the Brenner trial seems consistent with the lack of effect on NAD+ in both studies and the lack of effect on mito respiration here, and contradictory to the rodent studies (though those have looked at endurance running, and not at strength to my recollection). It may be significant that Exercise Boosts NAMPT Levels in Humans, Especially in Older People (PMID: 31207144), and that "There are conflicting results in both animal and human studies as to whether or not exercise increases or decreases NAD+, NADH, and the NAD+/NADH ratio."
Edited by Michael, 14 November 2019 - 03:03 AM.